Cargando…

Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer

BACKGROUND: Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer death among women in the United States (5 % of cancer deaths). The standard treatment for patients with advanced EOC is initial debulking surgery followed by carboplatin-paclitaxel combination chemotherapy. Unfortunatel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raghavan, Rama, Hyter, Stephen, Pathak, Harsh B., Godwin, Andrew K., Konecny, Gottfried, Wang, Chen, Goode, Ellen L., Fridley, Brooke L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069875/ https://www.ncbi.nlm.nih.gov/pubmed/27756228 http://dx.doi.org/10.1186/s12864-016-3149-5

Ejemplares similares

Developing a genetic signature to predict drug response in ovarian cancer
por: Hyter, Stephen, et al.
Publicado: (2017)

Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes
por: Way, Gregory P., et al.
Publicado: (2016)

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence
por: Fridley, Brooke L., et al.
Publicado: (2016)

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
por: Wang, Chen, et al.
Publicado: (2016)

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes
por: Earp, Madalene A, et al.
Publicado: (2017)

Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer
por: Konecny, Gottfried E.
Publicado: (2019)

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
por: Jatoi, Aminah, et al.
Publicado: (2015)

Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells
por: Do, Thuy-Vy, et al.
Publicado: (2017)

Assessment of data transformations for model-based clustering of RNA-Seq data
por: Noel-MacDonnell, Janelle R., et al.
Publicado: (2018)

Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
por: Braun, Mitchell W, et al.
Publicado: (2020)

DNA Methylation in Ovarian Cancer Susceptibility
por: Reid, Brett M., et al.
Publicado: (2020)

No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer
por: Goode, Ellen L, et al.
Publicado: (2009)

Subject level clustering using a negative binomial model for small transcriptomic studies
por: Li, Qian, et al.
Publicado: (2018)

Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer
por: Larson, Nicholas B, et al.
Publicado: (2014)

A Latent Model for Prioritization of SNPs for Functional Studies
por: Fridley, Brooke L., et al.
Publicado: (2011)

Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer
por: Koestler, Devin C, et al.
Publicado: (2014)

Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer
por: Natanzon, Yanina, et al.
Publicado: (2018)

Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome
por: Fridley, Brooke L, et al.
Publicado: (2014)

Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines
por: Li, Liang, et al.
Publicado: (2014)

European American Stratification in Ovarian Cancer Case Control Data: The Utility of Genome-Wide Data for Inferring Ancestry
por: Raska, Paola, et al.
Publicado: (2012)

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
por: White, Kristin L, et al.
Publicado: (2009)

Germline Copy Number Variation and Ovarian Cancer Survival
por: Fridley, Brooke L., et al.
Publicado: (2012)

Geoinformation: remote sensing, photogrammetry, and geographic information systems
por: Konecny, Gottfried
Publicado: (2014)

Updates on drug discovery in ovarian cancer
por: Gibson, Steven J, et al.
Publicado: (2014)

Probabilistic drug connectivity mapping
por: Parkkinen, Juuso A, et al.
Publicado: (2014)

An ensemble-based Cox proportional hazards regression framework for predicting survival in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Meier, Richard, et al.
Publicado: (2016)

Analysis of variation in NF-κB genes and expression levels of NF-κB-regulated molecules
por: Liu-Mares, Wen, et al.
Publicado: (2007)

Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma
por: Kelemen, Linda E., et al.
Publicado: (2012)

Nonlinear mixed-effects models for modeling in vitro drug response data to determine problematic cancer cell lines
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2019)

The sky atlas: the greatest maps, myths and discoveries of the universe
por: Brooke-Hitching, Edward
Publicado: (2019)

Rapid Discovery of Potential Drugs for Osteonecrosis of Femoral Head Based on Gene Expression Omnibus Database and Connectivity Map
por: Luo, Di, et al.
Publicado: (2019)

Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
por: Freed, Ian M., et al.
Publicado: (2023)

Single versus multiple imputation for genotypic data
por: Fridley, Brooke L, et al.
Publicado: (2009)

Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
por: Jiang, Jun, et al.
Publicado: (2022)

Case report: Invasive fungal infection in a patient with a rare CVID-causing gene (TNFRSF13B) mutation undergoing AML treatment
por: Tabak, Carine, et al.
Publicado: (2023)

Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening
por: Salame, Natasha, et al.
Publicado: (2022)

Comparison of tagging single-nucleotide polymorphism methods in association analyses
por: Goode, Ellen L, et al.
Publicado: (2007)

The genetics of gene expression: comparison of linkage scans using two phenotype normalization methods
por: de Andrade, Mariza, et al.
Publicado: (2007)

Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer
por: Goode, Ellen L., et al.
Publicado: (2013)

Linkage analysis using principal components of gene expression data
por: Atkinson, Elizabeth J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_8lsf18fg27cjgl5tre1rdctg5i